Tamsulosin Hydrochloride
Product Images NDC 67046-720

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tamsulosin Hydrochloride (NDC 67046-720). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Contract Pharmacy Services-pa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structured Formula For Tamsulosin (7350ad6e 7745 4743 9aa4 2a14ff01fef4 01)

Chemical structure of Tamsulosin Hydrochloride, showing its molecular arrangement including aromatic rings, nitro, methoxy, and ethoxy groups, along with the hydrochloride moiety.*

FDA Label Image

Structured Formula For Tamsulosin (7350ad6e 7745 4743 9aa4 2a14ff01fef4 02)

A line graph showing plasma concentration (mg/mL) versus time (hours) comparing the pharmacokinetic profiles of Tamsulosin Hydrochloride under fasted and fed conditions. The graph includes two curves representing plasma concentration over 36 hours, with the fasted state curve peaking higher and earlier than the fed state.*

FDA Label Image

Structured Formula For Tamsulosin (7350ad6e 7745 4743 9aa4 2a14ff01fef4 03)

A line graph comparing the mean change over duration of treatment in weeks for three groups: 0.8 mg treatment, 0.4 mg treatment, and placebo. The x-axis shows duration from baseline to 13 weeks, and the y-axis shows mean change from 0 to -10. Sample sizes at each time point are indicated. The 0.8 mg group shows the greatest mean change, followed by 0.4 mg, with placebo showing the least change.*

FDA Label Image

Structured Formula For Tamsulosin (7350ad6e 7745 4743 9aa4 2a14ff01fef4 04)

A line graph depicting mean change over duration of treatment (weeks) for Tamsulosin Hydrochloride 0.4 mg, 0.8 mg, and placebo groups. The x-axis shows treatment duration from 0 to 13 weeks plus LOCF, and the y-axis represents mean change values. Data points with sample sizes are indicated for each group over time.*

FDA Label Image

Structured Formula For Tamsulosin (7350ad6e 7745 4743 9aa4 2a14ff01fef4 05)

A line graph depicting the mean change in a variable measured in mL/sec over a treatment duration ranging from baseline to 14 weeks and last observed carry forward (LOCF). The graph compares three groups: treatment with 0.8 mg dose, treatment with 0.4 mg dose, and placebo. Mean changes appear highest for 0.8 mg and 0.4 mg doses, while placebo shows minimal change over time.*

FDA Label Image

Structured Formula For Tamsulosin (7350ad6e 7745 4743 9aa4 2a14ff01fef4 06)

A line graph showing mean change in mL/sec over treatment duration in weeks comparing three treatments: 0.8 mg, 0.4 mg, and placebo. The chart tracks data from baseline up to 13 weeks and includes a last observation carried forward (LOCF) point, illustrating effectiveness trends of the treatments over time.*

FDA Label Image

Blister Of 30 Capsules (7350ad6e 7745 4743 9aa4 2a14ff01fef4 07)

Label for Tamsulosin Hydrochloride 0.4 mg capsules, quantity 30, packaged by Contract Pharmacy Services-PA. The label includes a patient medication calendar with numbered days and spaces for daily dosing tracking, along with storage instructions and prescription details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.